Bioasis Technologies Revenue, Profits - BIOAF Annual Income Statement

Add to My Stocks
$0.31 $0.01 (3.13%) BIOAF stock closing price Sep 18, 2018 (Closing)

Looking at financial statements, along with the Bioasis Technologies stock price, it's management, its economic moat, and industry competitors forms an important part of fundamental analysis. In the income statement, an investor can look at important parameters like revenue or sales, gross profits, net profits, and EPS basic to gain deeper insights. The income statement is always for an accounting period, typically for a year or quarter, and affects the stock. In this case, the BIOAF stock is bound to reflect the impact of the YOY decline of 0. The operating expenses as shown in the Bioasis Technologies profit and loss statement for 2017 total to $1.74M. This line item shows that the operating expenses has increased compared with last year. Also check: Bioasis Technologies assets and Bioasis Technologies free cash flow.

View revenue and profit details for latest and last 10 financial years.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Mar - Feb201720162015201420132012
Bioasis Technologies Revenues or Net Sales
------
Cost Of Goods Sold (COGS)------
Bioasis Technologies Gross Profit
--0.04M----
Research & Development Expense--1.2M1.91M1.92M1.12M
Selling General & Admin Expense1.74M1.27M1.32M1.56M3.07M1.84M
Income Before Depreciation Depletion Amortization-2.27M-1.96M-2.53M-3.48M-5M-2.96M
Depreciation Depletion Amortization------
Non Operating Income--0.01M----
Interest Expense------
Bioasis Technologies Pretax Income
-2.28M-1.97M-2.52M-3.45M-4.96M-2.96M
Provision for Income Taxes------
MinorityInterest------
Investment Gains Losses------
Other Income------
Income Before Extraordinaries & Disc Operations-2.28M-1.97M-2.52M-3.45M-4.96M-2.96M
Extraordinary Items & Discontinued Operations------
Bioasis Technologies Profit/ Loss (Net Income)
-2.28M-1.97M-2.52M-3.45M-4.96M-2.96M
Average Shares used to compute Diluted EPS45.42M44.44M-40.84M37.99M32.57M
Average Shares used to compute Basic EPS45.42M44.44M-40.84M37.99M32.57M
Income Before Nonrecurring Items-2.28M-1.97M--3.46M-4.97M-2.97M
Income from Nonrecurring Items------
Bioasis Technologies Earnings Per Share Basic Net
-0.05-0.04-0.06-0.08-0.13-0.09
Bioasis Technologies Earnings Per Share Diluted Net
-0.05-0.04--0.08-0.13-0.09
EPS Diluted Before Nonrecurring Items-0.05-0.04--0.08-0.13-0.09
Preferred Dividends Acc Pd------
Dividends Common------
Dividend Per Share Common0.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Click here to view our Ascendis Pharma financial analysis

Bioasis Technologies stock analysis involves checking at least a few of the important things like:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $- for this year of 2017. Our Bioasis Technologies revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $-2.28M for Bioasis Technologies for 2017. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.

The income statement is also called the profit and loss statement. Apart from the BIOAF income statement, one can check the Bioasis Technologies historical stock prices to check how the price has moved with time.

Bioasis Technologies Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
48.7
Operating Margin
0
Dividend Yield
0%